GW Pharmaceuticals Announces Second Positive Phase 3 Pivotal Trial
“This new important EPIDIOLEX data is good news for the Dravet syndrome community and offers further scientific evidence for this newly available therapy,”
EPIDIOLEX® (cannabidiol) Oral Solution – the First FDA-approved Plant-derived Cannabinoid Medicine – Now Available by Prescription in the U.S.
The availability of EPIDIOLEX is an important milestone for patients
Epidiolex is the first marijuana based medicine approved by the FDA
“This is an important medical advance,”
Epidiolex and GW Pharma should know if FDA approved by the end of the month
“The future of the industry is showing itself here,” Sederberg said. “There’s going to be the pharmaceutical lane, the nutraceutical (food-as-medicine) lane, the adult-use lane. This shows how that’s all coming together.”